Welcome to LookChem.com Sign In|Join Free
  • or
Tert-butyl [6-(hydroxymethyl)pyridin-2-yl]carbamate is a chemical compound with the molecular formula C12H18N2O3. It belongs to the class of organic compounds known as pyridines and derivatives, which are compounds containing a pyridine ring, a six-membered aromatic heterocycle consisting of one nitrogen atom and five carbon atoms. tert-butyl [6-(hydroxymethyl)pyridin-2-yl]carbamate is characterized by a tert-butyl carbamate group attached to the 6-(hydroxymethyl) pyridin-2-yl moiety. Its physical and chemical properties, such as solubility, melting point, and boiling point, may vary depending on its state or the conditions under which it is stored.

203321-83-9

Post Buying Request

203321-83-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

203321-83-9 Usage

Uses

Used in Pharmaceutical Industry:
Tert-butyl [6-(hydroxymethyl)pyridin-2-yl]carbamate is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique structure and functional groups make it a valuable building block in the development of new therapeutic agents.
Used in Chemical Research:
In the field of chemical research, tert-butyl [6-(hydroxymethyl)pyridin-2-yl]carbamate serves as a versatile compound for studying the properties and reactions of pyridine derivatives. It can be used to explore the reactivity of the tert-butyl carbamate group and its influence on the chemical behavior of the molecule.
Used in Material Science:
Tert-butyl [6-(hydroxymethyl)pyridin-2-yl]carbamate may also find applications in material science, where its unique structure and properties can be utilized to develop new materials with specific characteristics. For example, it could be used in the synthesis of polymers, coatings, or other materials with tailored properties.
The applications and potential hazards of tert-butyl [6-(hydroxymethyl)pyridin-2-yl]carbamate depend on its purity and the specific industry in which it is used. It is essential to consider the safety and regulatory requirements when handling and utilizing tert-butyl [6-(hydroxymethyl)pyridin-2-yl]carbamate in various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 203321-83-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,3,3,2 and 1 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 203321-83:
(8*2)+(7*0)+(6*3)+(5*3)+(4*2)+(3*1)+(2*8)+(1*3)=79
79 % 10 = 9
So 203321-83-9 is a valid CAS Registry Number.

203321-83-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-[6-(hydroxymethyl)pyridin-2-yl]carbamate

1.2 Other means of identification

Product number -
Other names tert-Butyl (6-(hydroxymethyl)pyridin-2-yl)carbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:203321-83-9 SDS

203321-83-9Relevant academic research and scientific papers

Efficient synthesis of tert-Butyl (6-Formylpyridin-2-yl)carbamic acid

Majgier-Baranowska, Helena,Li, Bing,Peet, Norton P.

, p. 1173 - 1180 (2013)

We have developed an efficient four-step synthesis of tert-butyl (6-formylpyridin-2-yl)carbamic acid (1) in 80% overall yield using inexpensive starting material and reagents and no air-sensitive reagents. Column chromatography was not required for purification of the intermediates or the final product.

POLY HETEROCYCLIC CONJUGATES AND THEIR PHARMACEUTICAL USES

-

Paragraph 0039-0040; 0043, (2022/01/04)

Compounds of Formula (I) shown below and a pharmaceutical composition containing one of the compounds: Each of the variables is defined herein. Also disclosed is a method of treating a condition associated with uncontrolled cell growth with a compound of Formula (I).

Phenyl oxime derivative and preparation method and application thereof

-

Paragraph 0113-0114, (2020/12/31)

The invention relates to a phenyl oxime derivative as well as a preparation method and application thereof. Specifically, the present invention relates to a phenyl oxime derivative represented by formula (I) or a stereoisomer of the phenyl oxime derivativ

THIOBENZOIMIDAZOLE AS FUNGICIDES

-

Page/Page column 65; 75, (2018/08/03)

The present invention relates to 2-thiobenzimidazoles of formula (I) which are of use as fungicides.

AGRICULTURAL CHEMICALS

-

, (2017/11/10)

The present invention relates to compounds which are of use in the field of agriculture as fungicides.

SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS

-

Paragraph 0778; 0779, (2017/04/04)

Provided herein are novel substituted bicyclic aza-heterocycle sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS

-

Paragraph 0360; 0361, (2016/08/17)

Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

An affinity reagent for the recognition of pyrophosphorylated peptides

Conway, John H.,Fiedler, Dorothea

supporting information, p. 3941 - 3945 (2015/03/30)

A resin-bound dinuclear zinc(II) complex for the selective capture of pyrophosphopeptides is reported. The metal complex binds diphosphate esters over other anionic groups, such as monophosphate esters, sulfate esters, and carboxylic acids, with high spec

2-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS

-

Paragraph 00210, (2013/04/24)

The invention provides certain 2-pyridyl carboxamide-containing compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein A and B are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.

SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS

-

Page/Page column 196, (2013/05/09)

Provided herein are novel substituted bicyclic aza-heterocycle sirtuin- modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin- modulating compound in combination with another therapeutic agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 203321-83-9